{"id":43422,"date":"2025-10-15T16:03:39","date_gmt":"2025-10-15T08:03:39","guid":{"rendered":"https:\/\/flcube.com\/?p=43422"},"modified":"2025-10-15T16:03:40","modified_gmt":"2025-10-15T08:03:40","slug":"jiudian-pharma-acquires-chengdu-peides-jij02-gel-advancing-a-novel-acne-treatment-into-phase-1","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=43422","title":{"rendered":"Jiudian\u202fPharma Acquires Chengdu Peide\u2019s JIJ02 Gel, Advancing a Novel Acne Treatment into Phase\u202f1"},"content":{"rendered":"\n<p>Hunan Jiudian Pharmaceutical Co., Ltd. (<a href=\"https:\/\/www.google.com\/finance\/quote\/300705:SHE\">SHE: 300705<\/a>) today announced the acquisition of all developed results and intellectual property rights for <strong>JIJ02 Gel<\/strong> (formerly \u201cPD\u2011DP\u2011008 Gel\u201d) from Chengdu Peide Biopharmaceutical Co., Ltd. The transaction, valued at <strong>90\u202fmillion yuan<\/strong>, includes a comprehensive technology\u2011transfer agreement that positions Jiudian to advance the Category\u202f1 chemical drug into Phase\u202f1 clinical trials.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-rationale\">Strategic Rationale<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>First\u2011in\u2011class Candidate<\/strong> \u2013 JIJ02 Gel is specifically designed for <strong>acne vulgaris<\/strong>, a condition affecting millions worldwide.<\/li>\n\n\n\n<li><strong>Reduced Resistance &amp; Superior Safety<\/strong> \u2013 Early data suggest lower propensity for drug\u2011resistance development and an improved safety profile compared with existing topical treatments such as benzoyl peroxide and retinoids.<\/li>\n\n\n\n<li><strong>Unmet Market Need<\/strong> \u2013 No domestic or international product of this class has yet entered the market, offering Jiudian a unique competitive edge.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-transaction-highlights\">Transaction Highlights<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Acquiring Company<\/strong><\/td><td>Jiudian\u202fPharma (SHE:\u202f300705)<\/td><\/tr><tr><td><strong>Target Company<\/strong><\/td><td>Chengdu Peide Biopharma<\/td><\/tr><tr><td><strong>Asset<\/strong><\/td><td>JIJ02 Gel (PD\u2011DP\u2011008 Gel) \u2013 Phase\u202f1 candidate<\/td><\/tr><tr><td><strong>Purchase Price<\/strong><\/td><td>90\u202fmillion yuan<\/td><\/tr><tr><td><strong>Contract<\/strong><\/td><td>Full technology\u2011transfer and IP rights<\/td><\/tr><tr><td><strong>Next Milestone<\/strong><\/td><td>Phase\u202f1 clinical trial initiation (scheduled Q4\u202f2025)<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-implications\">Market Implications<\/h2>\n\n\n\n<p>Jiudian\u2019s acquisition expands its dermatology pipeline and strengthens its position within China\u2019s growing specialty\u2011pharma sector. The company plans to leverage its manufacturing capabilities and regulatory expertise to accelerate the clinical development timetable and potentially secure early market entry ahead of competitors.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-forward-looking-statements\">Forward\u2011Looking Statements<\/h3>\n\n\n\n<p>The information in this release contains forward\u2011looking statements that involve risks and uncertainties. Actual results may differ materially.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/\u4e5d\u5178\u5236\u836f\uff1a\u5173\u4e8e\u53d7\u8ba9\u53d6\u5f97\u836f\u7269\u4e34\u5e8a\u8bd5\u9a8c\u6279\u51c6\u901a\u77e5\u4e66\u7684\u516c\u544a.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of \u4e5d\u5178\u5236\u836f\uff1a\u5173\u4e8e\u53d7\u8ba9\u53d6\u5f97\u836f\u7269\u4e34\u5e8a\u8bd5\u9a8c\u6279\u51c6\u901a\u77e5\u4e66\u7684\u516c\u544a.\"><\/object><a id=\"wp-block-file--media-19484b3c-5563-480a-b46a-99112ae6a2d3\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/\u4e5d\u5178\u5236\u836f\uff1a\u5173\u4e8e\u53d7\u8ba9\u53d6\u5f97\u836f\u7269\u4e34\u5e8a\u8bd5\u9a8c\u6279\u51c6\u901a\u77e5\u4e66\u7684\u516c\u544a.pdf\">\u4e5d\u5178\u5236\u836f\uff1a\u5173\u4e8e\u53d7\u8ba9\u53d6\u5f97\u836f\u7269\u4e34\u5e8a\u8bd5\u9a8c\u6279\u51c6\u901a\u77e5\u4e66\u7684\u516c\u544a<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/\u4e5d\u5178\u5236\u836f\uff1a\u5173\u4e8e\u53d7\u8ba9\u53d6\u5f97\u836f\u7269\u4e34\u5e8a\u8bd5\u9a8c\u6279\u51c6\u901a\u77e5\u4e66\u7684\u516c\u544a.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-19484b3c-5563-480a-b46a-99112ae6a2d3\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Hunan Jiudian Pharmaceutical Co., Ltd. (SHE: 300705) today announced the acquisition of all developed results&#8230;<\/p>\n","protected":false},"author":1,"featured_media":43427,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10,11],"tags":[30,3949,4386,4385],"class_list":["post-43422","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","category-drug","tag-biotech","tag-jiudian-pharmaceutical","tag-peide-biopharmaceutical","tag-she-300705"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Jiudian\u202fPharma Acquires Chengdu Peide\u2019s JIJ02 Gel, Advancing a Novel Acne Treatment into Phase\u202f1 - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Hunan Jiudian Pharmaceutical Co., Ltd. (SHE: 300705) today announced the acquisition of all developed results and intellectual property rights for JIJ02 Gel (formerly \u201cPD\u2011DP\u2011008 Gel\u201d) from Chengdu Peide Biopharmaceutical Co., Ltd. The transaction, valued at 90\u202fmillion yuan, includes a comprehensive technology\u2011transfer agreement that positions Jiudian to advance the Category\u202f1 chemical drug into Phase\u202f1 clinical trials.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=43422\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Jiudian\u202fPharma Acquires Chengdu Peide\u2019s JIJ02 Gel, Advancing a Novel Acne Treatment into Phase\u202f1\" \/>\n<meta property=\"og:description\" content=\"Hunan Jiudian Pharmaceutical Co., Ltd. (SHE: 300705) today announced the acquisition of all developed results and intellectual property rights for JIJ02 Gel (formerly \u201cPD\u2011DP\u2011008 Gel\u201d) from Chengdu Peide Biopharmaceutical Co., Ltd. The transaction, valued at 90\u202fmillion yuan, includes a comprehensive technology\u2011transfer agreement that positions Jiudian to advance the Category\u202f1 chemical drug into Phase\u202f1 clinical trials.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=43422\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-15T08:03:39+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-15T08:03:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1509.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43422#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43422\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Jiudian\u202fPharma Acquires Chengdu Peide\u2019s JIJ02 Gel, Advancing a Novel Acne Treatment into Phase\u202f1\",\"datePublished\":\"2025-10-15T08:03:39+00:00\",\"dateModified\":\"2025-10-15T08:03:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43422\"},\"wordCount\":256,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43422#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/1509.webp\",\"keywords\":[\"Biotech\",\"Jiudian Pharmaceutical\",\"Peide Biopharmaceutical\",\"SHE: 300705\"],\"articleSection\":[\"Company\",\"Deals\",\"Drug\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=43422#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43422\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=43422\",\"name\":\"Jiudian\u202fPharma Acquires Chengdu Peide\u2019s JIJ02 Gel, Advancing a Novel Acne Treatment into Phase\u202f1 - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43422#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43422#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/1509.webp\",\"datePublished\":\"2025-10-15T08:03:39+00:00\",\"dateModified\":\"2025-10-15T08:03:40+00:00\",\"description\":\"Hunan Jiudian Pharmaceutical Co., Ltd. (SHE: 300705) today announced the acquisition of all developed results and intellectual property rights for JIJ02 Gel (formerly \u201cPD\u2011DP\u2011008 Gel\u201d) from Chengdu Peide Biopharmaceutical Co., Ltd. The transaction, valued at 90\u202fmillion yuan, includes a comprehensive technology\u2011transfer agreement that positions Jiudian to advance the Category\u202f1 chemical drug into Phase\u202f1 clinical trials.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43422#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=43422\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43422#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/1509.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/1509.webp\",\"width\":1080,\"height\":608,\"caption\":\"Jiudian\u202fPharma Acquires Chengdu Peide\u2019s JIJ02 Gel, Advancing a Novel Acne Treatment into Phase\u202f1\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43422#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Jiudian\u202fPharma Acquires Chengdu Peide\u2019s JIJ02 Gel, Advancing a Novel Acne Treatment into Phase\u202f1\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Jiudian\u202fPharma Acquires Chengdu Peide\u2019s JIJ02 Gel, Advancing a Novel Acne Treatment into Phase\u202f1 - Insight, China&#039;s Pharmaceutical Industry","description":"Hunan Jiudian Pharmaceutical Co., Ltd. (SHE: 300705) today announced the acquisition of all developed results and intellectual property rights for JIJ02 Gel (formerly \u201cPD\u2011DP\u2011008 Gel\u201d) from Chengdu Peide Biopharmaceutical Co., Ltd. The transaction, valued at 90\u202fmillion yuan, includes a comprehensive technology\u2011transfer agreement that positions Jiudian to advance the Category\u202f1 chemical drug into Phase\u202f1 clinical trials.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=43422","og_locale":"en_US","og_type":"article","og_title":"Jiudian\u202fPharma Acquires Chengdu Peide\u2019s JIJ02 Gel, Advancing a Novel Acne Treatment into Phase\u202f1","og_description":"Hunan Jiudian Pharmaceutical Co., Ltd. (SHE: 300705) today announced the acquisition of all developed results and intellectual property rights for JIJ02 Gel (formerly \u201cPD\u2011DP\u2011008 Gel\u201d) from Chengdu Peide Biopharmaceutical Co., Ltd. The transaction, valued at 90\u202fmillion yuan, includes a comprehensive technology\u2011transfer agreement that positions Jiudian to advance the Category\u202f1 chemical drug into Phase\u202f1 clinical trials.","og_url":"https:\/\/flcube.com\/?p=43422","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-10-15T08:03:39+00:00","article_modified_time":"2025-10-15T08:03:40+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1509.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=43422#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=43422"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Jiudian\u202fPharma Acquires Chengdu Peide\u2019s JIJ02 Gel, Advancing a Novel Acne Treatment into Phase\u202f1","datePublished":"2025-10-15T08:03:39+00:00","dateModified":"2025-10-15T08:03:40+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=43422"},"wordCount":256,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=43422#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1509.webp","keywords":["Biotech","Jiudian Pharmaceutical","Peide Biopharmaceutical","SHE: 300705"],"articleSection":["Company","Deals","Drug"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=43422#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=43422","url":"https:\/\/flcube.com\/?p=43422","name":"Jiudian\u202fPharma Acquires Chengdu Peide\u2019s JIJ02 Gel, Advancing a Novel Acne Treatment into Phase\u202f1 - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=43422#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=43422#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1509.webp","datePublished":"2025-10-15T08:03:39+00:00","dateModified":"2025-10-15T08:03:40+00:00","description":"Hunan Jiudian Pharmaceutical Co., Ltd. (SHE: 300705) today announced the acquisition of all developed results and intellectual property rights for JIJ02 Gel (formerly \u201cPD\u2011DP\u2011008 Gel\u201d) from Chengdu Peide Biopharmaceutical Co., Ltd. The transaction, valued at 90\u202fmillion yuan, includes a comprehensive technology\u2011transfer agreement that positions Jiudian to advance the Category\u202f1 chemical drug into Phase\u202f1 clinical trials.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=43422#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=43422"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=43422#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1509.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1509.webp","width":1080,"height":608,"caption":"Jiudian\u202fPharma Acquires Chengdu Peide\u2019s JIJ02 Gel, Advancing a Novel Acne Treatment into Phase\u202f1"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=43422#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Jiudian\u202fPharma Acquires Chengdu Peide\u2019s JIJ02 Gel, Advancing a Novel Acne Treatment into Phase\u202f1"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1509.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/43422","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=43422"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/43422\/revisions"}],"predecessor-version":[{"id":43428,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/43422\/revisions\/43428"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/43427"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=43422"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=43422"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=43422"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}